Details for New Drug Application (NDA): 204928
✉ Email this page to a colleague
The generic ingredient in ZAFIRLUKAST is zafirlukast. There are four drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the zafirlukast profile page.
Summary for 204928
Tradename: | ZAFIRLUKAST |
Applicant: | Rising Pharms |
Ingredient: | zafirlukast |
Patents: | 0 |
Formulation / Manufacturing: | see details |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
Approval Date: | Aug 25, 2022 | TE: | AB | RLD: | No |
Profile for product number 002
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 20MG | ||||
Approval Date: | Aug 25, 2022 | TE: | AB | RLD: | No |
Complete Access Available with Subscription